0001750019-19-000025.txt : 20190412 0001750019-19-000025.hdr.sgml : 20190412 20190412160900 ACCESSION NUMBER: 0001750019-19-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cardama Alfonso Quintas CENTRAL INDEX KEY: 0001760104 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 19746379 MAIL ADDRESS: STREET 1: C/O TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_155509972563704.xml FORM 4 X0306 4 2019-04-11 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001760104 Cardama Alfonso Quintas TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 16.11 2019-04-11 4 A 0 211302 0 A 2029-04-10 Common Stock 211302.0 211302 D 25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. /s/ Margaret Siegel as Attorney-in-Fact 2019-04-12